about
Preneoplastic lesions of the lungOvine pulmonary adenocarcinoma: a large animal model for human lung cancerThe intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathwayLung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoterHuman cancer long non-coding RNA transcriptomes.Molecular characterization of lung dysplasia induced by c-Raf-1.Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGEMolecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.Epidermal growth factor receptor gene amplification in atypical adenomatous hyperplasia of the lung.DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology.Heme oxygenase in neonatal lung injury and repairRandomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules.Lung cancer--where are we today? Current advances in staging and nonsurgical treatment.Pathohistological changes of tracheal epithelium in laryngectomized patients.Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer.Thyroid transcription factor 1 in pulmonary adenocarcinomaAnalysis of lung tumor initiation and progression in transgenic mice for Cre-inducible overexpression of Cul4A gene.Optical detection of preneoplastic lesions of the central airwaysDiffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report.Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-gamma Ligands in Lung Cancer.Multiphoton microscopy and microspectroscopy for diagnostics of inflammatory and neoplastic lung.Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesEGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups.Computational systems biology in cancer: modeling methods and applications.Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancerPotential utility of p63 expression in differential diagnosis of non-small-cell lung carcinoma and its effect on prognosis of the disease.Therapeutical measures to control airway tolerance in asthma and lung cancer.Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasRecurrence of squamous cell lung carcinoma is associated with the co-presence of reactive lesions in tumor-adjacent bronchial epithelium.Histological types and significance of bronchial epithelial dysplasia.PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer.In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy.Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.The classification of lung carcinoma: time to change the morphology-based approach?Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed.
P2860
Q24807204-EB32A940-F1FE-49A2-A1CC-A9196830CD53Q28088774-E6A6EC76-1EB0-4E14-A8F8-20B8DD88C268Q28512744-129573F4-C4D2-41D9-BB52-FD49B47485FFQ28565657-3B5B820A-04E5-4246-8B83-ADB81B84F0B0Q31032840-350B86B1-A40C-4AD0-9191-730FE9CCB272Q33468458-3E7BED9C-3274-4520-B4CE-5752DDC081E3Q33531797-10311376-39CD-40B9-8D4C-692B6F811C71Q33760940-403AECD5-D821-4DA5-93C2-C49DE0EC0DEBQ33942092-CAB597A1-6D78-43F8-AF0D-D65A4B61DBD5Q33952447-24DF2DE2-217E-457C-9E73-B75BBA1FAF5FQ34231742-D0727AD6-FE24-4330-AD8F-7F553E02C96AQ34370838-64DD4923-BDB8-4099-B0F6-EEF452F0F525Q34472750-3F82832E-EE86-4644-8587-9CDD51231DD8Q34982142-37BF29B1-E0F5-4E87-96EE-F37513FDECD8Q35422998-A40FA6B4-6053-408C-A3E7-EF3661AE22A1Q35551845-6BEBE93D-C55A-43DE-A4F6-D32EAD77D87BQ35587561-AA60C922-23DD-40E8-93AC-6A5DDCA8473DQ35879413-3F4867D8-9D6A-4DB0-B8FB-E93DF2AF0A93Q35884805-BC986B33-D843-4F7B-9077-8F419D01ACD1Q36478722-B342B175-4C36-45AE-BAD9-E7555277DBE9Q36676421-BD8B60FD-6546-4A4A-8D64-89B4E4BA9E1EQ36700259-B7F154F0-7063-44BB-9F7C-8623468AF464Q37111529-00C0F665-9BDD-46DF-88C3-08FBA0BEEC84Q37198069-021284BB-FFAB-4DC3-B35B-64283849E1A7Q37380580-750374A3-6702-4C57-8835-1A99A6A0EF9EQ37413167-64204D81-FC89-480C-8237-2A975F2A42C3Q37595541-DDC1F7E5-6E9C-44A1-A1BD-4A20BFE3810AQ38031462-950AE74A-0725-4707-A5D5-22119711975BQ38538085-A2993E25-BDFD-4640-AF44-6DE8E14C0D98Q40424687-73321637-4F1A-42BA-979D-125CD8E6EBD1Q40442754-3682B89F-3B83-4991-85B9-BA49C9A896B8Q42489421-A4F24B3F-24C0-4E9C-A369-C262D756F0F6Q45989737-10BB74D2-BFB2-4C3E-AAAD-D91A3CACDD8FQ47293692-2FBF2DD0-0CE9-40EC-B2D9-D212FB41DD7FQ48032111-AB96D41B-50FC-4447-808E-B916E4DD3DE8Q51698466-ACDF9883-DB33-4F70-A9F1-3C5FC2CFDCA1Q54595548-9E6A113C-182D-4B7F-B5F5-119CFBD8DCDA
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pulmonary preinvasive neoplasia
@ast
Pulmonary preinvasive neoplasia
@en
Pulmonary preinvasive neoplasia
@nl
type
label
Pulmonary preinvasive neoplasia
@ast
Pulmonary preinvasive neoplasia
@en
Pulmonary preinvasive neoplasia
@nl
prefLabel
Pulmonary preinvasive neoplasia
@ast
Pulmonary preinvasive neoplasia
@en
Pulmonary preinvasive neoplasia
@nl
P2860
P356
P1476
Pulmonary preinvasive neoplasia
@en
P2093
P2860
P304
P356
10.1136/JCP.54.4.257
P407
P577
2001-04-01T00:00:00Z